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Interleukin 17(A) (IL-17) is a potent pro-inflammatory cytokine that acts as a central regulator of
inflammatory response within the brain, but its physiological roles under non-inflammatory conditions
remain elusive. Here we report that endogenous IL-17 ablates neurogenesis in the adult dentate gyrus (DG)
of hippocampus. Genetic deletion of IL-17 increased the number of adult-born neurons in the DG. Further,
we found that IL-17 deletion altered cytokine network, facilitated basal excitatory synaptic transmission,
enhanced intrinsic neuronal excitability, and increased expression of proneuronal genes in neuronal
progenitor cells (NPCs). Our findings suggest a profound role of IL-17 in the negative regulation of adult
hippocampal neurogenesis under physiology conditions.

N

eurogenesis in the subgranular zone (SGZ) of dentate gyrus is a major mechanism that occurs in the adult
hippocampus to maintain its function and plasticity in response to extrinsic and intrinsic changes1–3.
Abnormal neurogenesis in SGZ is likely to exacerbate major neurological disorders such as Alzheimer’s
disease, depression and drug addiction1,4–6. An understanding of how adult-born neurons develop and integrate
into preformed neural networks may suggest targets for therapeutic intervention and assist in developing stem
cell therapies for repairing damaged neuronal tissue7,8.
Environmental factors such as inflammatory mediators can influence neurogenesis9,10. Among these inflammatory mediators, interleukin 17 (A) (IL-17) has been found to play a pivotal role in the pathogenesis of
numerous inflammatory diseases in the central nervous system (CNS), such as multiple sclerosis and stroke11,12.
IL-17 acts synergistically with tumor necrosis factor (TNF) and IL-1 to shape CNS inflammation. Besides Th17
cells, a variety of cell types can produce IL-17 including cd T cells, natural killer (NK) cells, NKT cells and
lymphoid tissue inducer cells. In addition to immune cells, glial cells in the CNS also express IL-17 under
physiology conditions13–15. IL-17 functions through a distinct ligand-receptor signaling system, IL-17 receptor
(IL-17R), which is widely expressed and binds IL-17 with high affinity16. IL-17R deficiency results in reduced
chemokine levels17 and its signaling has been implicated in both innate and adaptive immunity18. Recently, the
expression of IL-17R has been detected within the CNS and upregulated under inflammatory conditions19,20.
However, little is known about the effects of IL-17 on neurogenesis under non-inflammatory conditions.
In this study, we examined the role of endogenous IL-17 in hippocampal neurogenesis under physiological
condition. Our results demonstrate that IL-17 is a negative regulator of adult hippocampal neurogenesis in the
DG of hippocampus. Using IL-17 KO mice, we provided evidence that the absence of IL-17 significantly
improved neurogenesis in the DG, enhanced synaptic function, reduced expression of inflammatory cytokines,
and increased expression of proneuronal genes in NPCs.

Methods
Animals. All mice were C57BL/6 background littermates and used at 2–3 months of age. IL-17 (A) KO mice were provided by Y. Iwakura
(University of Tokyo, Tokyo, Japan). All experiments were performed in accordance with approved guidelines set by the Barrow
Neurological Institute Ethical Committee.
Real-time RT-PCR. Total RNA was extracted from brain tissues or cultured progenitors with TRIzol (Invitrogen, CA). First-strand cDNA of
each sample was synthesized using a reverse transcription kit (Invitrogen, CA). RT-PCR was performed as we previously described21, using
an ABI Prism 7900-HT sequence system (Applied Biosystems, CA) with the QuantiTect SYBR Green PCR kit (QIAGEN, CA), in accordance
with the manufacturer’s instructions. The GAPDH gene was amplified and served as an endogenous control. All primer sequences used in
this study were listed in supplemental Table 1. 1 ml of first-strand cDNA product was amplified with platinum Taq polymerase (Invitrogen,
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CA) and gene-specific primer pairs. Each sample was assayed in triplicate and
experiments were repeated twice. The relative amounts of mRNA were calculated by
plotting the Ct (cycle number). The mean relative expression was determined by the
22DDCt comparative method and expressed by relative expression levels against housekeeping gene (i.e. GAPDH).
Cell cultures. The method for cultures of neurons from adult DG of mouse
hippocampus is the standard procedure as we previously described21,22. Briefly,
animals were sacrificed, and the DG of hippocampus was dissected under a
stereological microscope. Tissue was minced with scissors in ice-cold Neurobasal
medium (Invitrogen, Carlsbad, CA) and then digested with Papain (20 unit/mg,
Worthington, NJ) at 30uC for 20 min in tubes shaken at 120 rpm in a water bath
shaker. After enzyme digestion, the reaction was ceased by adding inactivated fetal
bovine serum into the medium. Then, digested tissue was filtered and transferred into
15 ml tubes. After trituration, tissue was centrifuged at 1500 rpm for 3 min to form
pellets containing dissociated cells, and the supernatant was removed and replaced
with Neurobasal medium, which was used to resuspend the pellets. This process was
repeated three times. After the final centrifugation, the supernatant was replaced with
Neurobasal medium supplemented with 0.5% (w/v) L-glutamine and 2% B27 serumfree supplement. Cells were re-suspended and counted based on Trypan blue
exclusion and plated at a density of 4.5–5.0 3 104 cells per cm2 in 35 mm Falcon
culture dishes (BD Biosciences, San Jose, California). Cells were kept within the 37uC/
5% CO2 incubator for future use.
Primary cultures of mouse astrocytes were prepared from the DG of C57BL/6
newly born mice (postnatal 1-3days) as previously described23. Briefly, the DG was
dissected under sterile conditions and the tissues were dissociated in 0.25% trypsin
(Invitrogen, CA) for 10 minutes at 37uC. The cell suspension was separated by
centrifugation at 1500 rpm for 5 minutes, and the cells were transferred to poly-Dlysine pre-coated cell culture flasks in DMEM containing 10% FCS, 100 U/ml penicillin and 100 mg/ml streptomycin. The cultures were maintained at 37uC in a
humidified atmosphere of 5% CO2 and 95% air. Before the experiments, the purity of
astrocytes in cultures was .95% determined by an astrocyte marker, GFAP (Santa
Cruz, CA). Cells were used for ELISA assay after 10-14days in culture.
To prepare primary microglial cells as previously described24, after reaching a
confluent monolayer of glial cells (10–14 days), microglia were separated from
astrocytes by shaking off for 5 h at 100 rpm and re-plated on 24-well plates. After
plating the microglia-enriched population for 48 h, cells were used for ELISA assay.
The purity was .98% as determined by a microglia marker, Iba-1 (Wako, NY).
NPC cultures. NPC cultures derived from adult mice hippocampus were performed
as previously described25. Briefly, mice were deeply anesthetized using halothane and
decapitated, and brains were removed. Hippocampi were dissected, pooled, and
dissociated in DMEM (Invitrogen, CA) containing 2.5 U/ml papain, 1 U/ml dispase
II, and 250 U/ml DNase 1 (Worthington Biochemical, NJ) for 45 min at 137uC.
Dissociated cells were purified on two Percoll (Sigma, MI) gradients, 35 and 65%. The
resulting cells were plated at 1 3 104 cells per well in uncoated 12-well culture plates in
DMEM/F-12, supplemented with 15 mm HEPES, 2 mm l-glutamine, 100 U/ml
penicillin, 100 mg/ml streptomycin, 0.25 mg/ml Amphotericin B (Calbiochem, CA),
N2 supplement (Invitrogen, CA), and 20 ng/ml basic FGF (Sigma, MI).
ELISA. Measurement of IL-17 levels in mouse DG homogenates and cultured cell
lysates was performed with an ELISA kit specific to murine IL-17 (A). Procedures
were carried out according to the manufacturer’s instructions (Invitrogen, CA).
Results are expressed in pg/mg protein for samples from DG homogenates or for
samples from cultured cell lysates. Data were from three individual experiments
performed in triplicate. A Multi-Analyte ELISArray kit (SABioscience) was used to
measure inflammatory cytokines in homogenates of WT and IL-17 KO DG tissues,
according to the manufacturer’s instructions, as we previously described26,27.
Flow cytometry. Single cell suspensions (0.5 3 106 cells) were prepared from cultured
neuron, astrocytes, microglia and NPCs and stained with fluorochrome-conjugated
antibodies27,28. GFAP, CD11b, NeuN, and IL-17 antibodies were purchased from
eBioscience and Santa Cruz. Antibodies were directly labeled with one of the
following fluorescent tags: FITC, PE, APC, or PerCP. Flow cytometric data were
collected on a FACSAria flow cytometer and analyzed with Diva software.
BrdU labeling. BrdU was injected intraperitoneally at 10 mg/ml in sterile 0.9% NaCl
to yield a single dose of 50 mg/g body weight on each of 4 consecutive days. Mice were
singly housed for 2 or 4 weeks after the initial injection until tissue preparation. After
perfusion, all steps were performed blind to genotype.
Tissue Preparation and immunohistochemistry. Mice were anesthetized by
intraperitoneal injection of 10 mg/ml ketamine and 1 mg/ml xylazine in sterile 0.9%
NaCl at a volume of 0.01 ml/g body weight. Toe pinch was used to determine
effectiveness of anesthesia. Animals were transcardially perfused with 4%
paraformaldehyde in phosphate-buffered saline (PBS). Whole brain was removed
and post-fixed in 4% PFA in PBS overnight, then equilibrated in 30% sucrose. Next,
the tissue was frozen, and coronal slices (40 mm) were cut using a cryostat microtome
and processed for BrdU immunohistochemistry.
For BrdU and neuron-specific nuclear protein (NeuN) double-labeled immunofluorescence, images were captured and quantitated by observers who were blind to
genotype. Free-floating sections were denatured in 2N HCl for 30 min at 37uC, rinsed
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in KPBS (to neutralize pH), preincubated with 2% goat and donkey serum in 0.3%
Triton X-100 for 1 h, and incubated overnight with rat anti-BrdU antibody (15100;
Santa Cruz, CA) and mouse anti-NeuN antibody (15100; Millipore, MA) or rabbit
anti-DCX (15100; Sigma, St. Louis, MO) or rabbit anti-GFAP (15100; Millipore, MA)
at 14uC. Sections were then rinsed and incubated in the dark for 2 h with Alexa Fluor
568 goat anti-rat IgG antibody (151000; Invitrogen, CA) and Alexa Fluor 488 donkey
anti-mouse IgG antibody (151000; Invitrogen, CA). Sections were washed with PBS 3
times for 10 minutes. Sections were then mounted on glass slides, and coverslipped
with glycerol-based mounting medium (for fluorescence microscopy). After
immunostaining, counts were made of BrdU-positive cells in the first third of the
granule cell layer in every fourth section through the entire hippocampus. Adult-born
neurons are mostly confined to the first third of the granule cell layer29. Imaging was
performed within 48 hours of immunostaining using a Leica TCS STED CW confocal
microscope. For BrdU1 cell counts in brain sections, images were captured mainly
from germinal regions but other areas were also screened to ensure a complete
analysis.
Colocalization of BrdU-positive cells with NeuN was validated using a confocal
scanning light microscope (MRC1024UV; Bio-Rad, Hemel Hempstead, UK) with
krypton/argon 488 and 568 excitation filter. A double-stained cell was defined as
having the strongest intensity of both stainings within the same or directly neighboring 1-mm-thick optical section through the cell in a consecutive Z-series of at least
four sections, with an overlap of the stainings in at least three sections. Stereological
estimations of the total number of BrdU1 cells in the SGZ of the dorsal hippocampal
formation were performed using the optical fractionator method25,30.
Hippocampal slice preparation. Hippocampal slices that were prepared as described
previously31,32. After isoflurane anesthesia, brain tissue was quickly removed and
bathed in cold (4uC) artificial cerebrospinal fluid (ACSF) containing (in mM): NaCl,
119; KCl, 2.5; NaHCO3, 26; MgSO2, 1.3; NaH2PO4, 1.0; CaCl2, 2.5; and glucose, 11.
The ACSF was continuously bubbled with 95% O2 - 5% CO2 (carbogen). Several
coronal sections (400 mm) containing the dorsal hippocampus were cut using a
vibratome (Vibroslice 725 M, WPI, Sarasota, FL) and transferred to a holding
chamber and incubated at room temperature (21 6 1uC) for at least 60 min prior to
recording.
Electrophysiology. Current-clamp recordings to measure neuronal excitability were
performed with a modified protocol as previously described21,33,34. Electrophysiology
recordings were performed by experimenters who were blind to genotype. All
recordings were performed at 31 6 1uC. Neuronal intrinsic excitability was measured
as the number of spikes in response to a series of fixed 500 ms current injection steps
(0, 0.03, 0.06, 0.09, 0.12, 0.15, 0.18, and 0.21 nA). Data were acquired by Axonpatch
200B amplifier at 2 kHz with pClamp 9.2 software (Molecular Devices, Sunnyvale,
CA) and analyzed with clampfit 9.2 software (Molecular Devices, Sunnyvale, CA) and
Mini Analysis software (Synaptosoft, Decatur, GA). For field potential recordings
from slices of hippocampal DG, a stimulating electrode was placed in the angular
bundle of the perforant path and a recording electrode in the hilus of the DG. A single
slice was transferred to a liquid-air interface chamber (Fine Science Tools, Inc., Foster
City, CA, USA) and suspended on a nylon net at the liquid-air interface in a bath of
continuously dripping oxygenated ACSF (2–2.5 ml/min).
Drugs and Solutions. All drugs used in this study were purchased from Sigma
(Sigma, St. Louis, MO). Mouse IL-17 was purchased from Cell Signaling (Cell
Signaling, MA). For patch-clamp recording from hippocampal cultures, the standard
external solution contained 140 mM NaCl, 3 mM KCl, 2 mM MgCl2, 2 mM CaCl2,
10 mM d-glucose, 10 mM HEPES, adjusted to pH 7.4 with Tris base. The internal
solution for current-clamp recordings to measure intrinsic excitability contained
130 mM KMeSO4, 10 mM KCl, 10 mM HEPES/K-HEPES, 2 mM MgSO4, 0.5 mM
EGTA and 3 mM ATP; the pH was adjusted to 7.3 with KOH. For AMPA receptormediated miniature EPSC (mEPSC) recordings, 0.3 mM TTX, 50 mM picrotoxin, and
50 mM APV were added into external solution. For whole-cell recordings of ligandgated ion channels, the internal solution contains the following: 140 mM potassium
gluconate, 5 mM KCl, 10 mM HEPES, 0.2 mM EGTA, 2 mM MgCl2, 4 mM
MgATP, 0.3 mM Na2GTP and 10 mM Na2-phosphocreatine (pH 7.3 with KOH).
For field potential recordings, the internal solution was 2 M NaCl.
Statistical analysis. Comparisons were performed using two-tailed student t-test or
one-way ANOVA as appropriate. Data are presented as means 6 SEM, and
differences are considered significant at p , 0.05. All statistical analyses were
conducted using Graphpad Prism 5 software.

Results
IL-17 and IL-17R are expressed in the DG of hippocampus. To
evaluate the expression of IL-17 and its receptor (IL-17R) in the DG
of hippocampus, we performed ELISA assay and found that IL-17
mRNA and protein are expressed in WT DG tissues (Figure 1A–B).
To identify the source of IL-17 in WT DG tissues, we cultured
astrocytes, microglia, neurons and NPCs. Thereafter, we used
fluorescent-activated cell sorting (FACS) with intracellular staining
to compare the expression of IL-17 among these cells. We found that
2
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Figure 1 | IL-17 and IL-17R are expressed in the DG of hippocampus. (A). Real-time RT-PCR results show expression of IL-17 messenger relative to
GAPDH in WT and IL-17 KO DG tissues. (B). Expression of IL-17R at protein level in WT and IL-17 KO DG tissues was confirmed using ELISA.
(C–D). Results from FACS intracellular staining of cultured astrocytes, microglia, neurons and NPCs show astrocytes as a major source of IL-17. (E). IL17R mRNA is expressed in cultured WT and IL-17 KO NPCs. (F–G). FACS analysis shows expression of IL-17R in cultured WT and IL-17 KO NPCs. Data
were obtained from three individual experiments performed in triplicate. Means 6 SEM; **p , 0.01.

astrocytes are the major source of IL-17 under physiological
condition (Figure 1C–D). To assess the expression of IL-17R on
NPCs, we examined the expression of IL-17R mRNA and protein
via RT-PCR and FACS, respectively. We found that majority of
NPCs expressed IL-17R (Figure F–G).
Genetic deletion of IL-17 promotes neurogenesis in the DG of
hippocampus. To determine whether endogenous IL-17 influences
adult-born neuron proliferation and survival, we birthdated adultborn neurons in wild-type (WT) and IL-17 knockout (KO) mice by
injecting BrdU and following their fate. Hippocampal slices were
taken for BrdU immunostaining after 2 and 4 weeks to allow
quantification before and after the critical period for activitydependent adult-born neuron proliferation and survival. A
significant increase in the number of BrdU-labeled cells was seen
in the dentate gyrus of IL-17 KO mice as compared to agematched WT mice at both 2 and 4 weeks (Figure 2A–B). The
results indicate that IL-17 signaling appears to negatively regulate
adult-born neurogenesis.
We then explored whether the absence of IL-17 can influence the
formation of immature and mature neurons. IL-17 KO and WT mice
were injected with BrdU once daily for 4 days and sacrificed 2 or 4
weeks. We found that the BrdU1 cells were distributed mainly in the
SGZ/GCL. Genetic deletion of IL-17 caused a significant increase in
the number of BrdU1 cells double labeled for both the specific marker of immature neurons (DCX) at 2 weeks after BrdU injections and
mature neurons (NeuN) in the SGZ/GCL compared to WT animals
at 4 weeks after BrdU injections (Figure 2C–F). These results suggest
that deletion of IL-17 increases both adult-born immature and
mature neurons in the DG of hippocampus.
Endogenous IL-17 regulates cytokine network in the DG of
hippocampus. IL-17 participates in pathogenesis of neurological
inflammatory diseases through an induction of inflammatory gene
expression in target cells. Our finding that the deletion of IL-17
promoted neurogenesis suggests that endogenous IL-17 may
influence cytokine environment in the DG. To test this possibility,
we compared expression profile of key pro-inflammatory cytokines
in the DG of hippocampus from IL-17 KO and WT mice. Using an
ELISA array kit, we found that the deletion of IL-17 reduced the
expression of TNF-a, IL-1b, IL-6, and IFN-c, as compared to WT
SCIENTIFIC REPORTS | 4 : 7554 | DOI: 10.1038/srep07554

controls (Figure 3). These data suggest that IL-17 deletion may
regulate the cytokine network in the DG, where progenitors reside.
Deficiency of IL-17 alters synaptic functions in the DG of
hippocampus. To investigate the neurophysiological consequences
of IL-17 deletion in the DG of hippocampus, we examined baseline
synaptic transmission and synaptic short- and long-term
potentiation (LTP) in the DG of hippocampus in both IL-17 KO
and WT mice. For field potential recordings from slices of
hippocampal DG, the stimulating electrode was placed in the
angular bundle of the perforant path and a recording electrode in
the hilus of the DG. We conducted a systematic evaluation of changes
in DG synaptic functions in IL-17 KO mice (Figure 4A). Although no
changes in LTP was observed (Figure 4B), we found that the input output (I/O) curve of field EPSP (fEPSP) slopes in response to
different stimulation intensities were shifted to the left when
compared with those of WT controls (Figure 4C), suggesting that
basal synaptic transmission was significantly enhanced in the DG of
IL-17 KO mice. We next examined synaptic short plasticity using
paired-pulse stimulation protocol and found that the paired-pulse
facilitation (PPF) was indistinguishable between IL-17 KO mice and
WT controls at 50 ms inter-pulse intervals. However, PPF was
significantly enhanced when the inter-pulse intervals were 100, 150
and 500 ms (Figure 4D). Therefore, short-lived presynaptic plasticity
was increased in IL-17 KO mice.
Increased intrinsic excitability and excitatory synaptic activities
on adult-born IL-17 KO neurons from the DG of hippocampus
cultures. Next, we compared neuronal intrinsic excitability and
glutamatergic inputs between these adult-born IL-17 KO neurons
and WT controls by performing somatic whole-cell current-clamp
recordings in cultured hippocampal DG neurons dissociated from
mice injected with BrdU (i.p. injected with Brdu for 4 days before cell
dissociation). After DIV for over 14 days, the cultured cells were
recorded and biocytin was microinjected afterward. Then biocytininjected cells were stained with streptavidin conjugated antibody and
anti-Brdu antibody to confirm that the recorded cells were newly
born from the DG of hippocampus following Brdu injections
(Figure 5A). We examined the effects of IL-17 deletion on intrinsic
membrane excitability in response to injection of a 90 pA current
from cultured BrdU1 neurons. Results showed that IL-17 deletion
increased neuronal excitability represented as an increase in spike
3
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Figure 2 | Genetic deficiency of IL-17 increases neurogenesis in the adult DG of hippocampus. (A). Confocal images of the DG showing BrdU (red) and
DAPI (blue) staining at 2 or 4 weeks after injection of BrdU to WT (top) and IL-17 KO (bottom) mice. (B). Quantification of BrdU-immunopositive cells
at 2 weeks (left; 2 WPI) and 4 weeks (right; 4 WPI) post-BrdU injection (mean 6 SEM; n 5 4 mice per condition). Scale bar, 100 mm. (C). Confocal
images of BrdU1DCX1 cells showing BrdU and DCX immunoreactivity as merged images at 2 weeks after 4 days of daily BrdU injections. (D). Number of
new immature neurons (BrdU1/DCX1) in the dentate subgranular zone/granule cell layer at 2 weeks after 4 days of daily BrdU injections. (E). Confocal
images of BrdU1NeuN1 cells showing BrdU and NeuN immunoreactivity as merged images at 4 weeks after 4 days of daily BrdU injections. (F). Number
of new immature neurons (BrdU1/NeuN1) in the dentate subgranular zone/granule cell layer at 4 weeks after 4 days of daily BrdU injections.
Means 6 SEM; n 5 6 for WT and IL-17 KO, respectively. **p , 0.01.

numbers (Figure 5B). I/O relationships derived from plots of spike
numbers occurring each 500 ms as a function of injected, different
depolarizing currents were used to evaluate neuronal excitability33,34.
IL-17 KO mice exhibited a significantly increase in neuronal
excitability represented as a left shift of I-O relationship curve (in
response to injected currents ranging from 0-180 pA) compared to
WT controls (Figure 5C). These results suggest that IL-17 deletion
enhances intrinsic excitability in the newly born neurons from DG of
hippocampus.
To test the impact of IL-17 deletion on synaptic excitatory glutamatergic activities, we examined the AMPA (2-amino-3-(5methyl-3-oxo-1,2- oxazol-4-yl) propanoic acid) receptor-mediated
miniature excitatory postsynaptic currents (mEPSCs) that occur
spontaneously in cultured neurons in the presence of tetrodotoxin.
We found a significant increase in both mEPSC amplitude
(Figure 5D–E) and frequency (Figure 5D–F) in cultured IL-17KO
BrdU1 neurons as compared to WT controls. Statistical analysis

demonstrated that the mEPSC amplitude was increased in IL-17
KO neurons as compared to that of WT controls (Figure 5E).
Meanwhile, mEPSC frequency was enhanced in IL-17KO neurons
as well (Figure 6F). These results suggest that deletion of IL-17 results
in increased mEPSC amplitude and frequency, which may be caused
by increased post-synaptic AMPARs levels and the probability of
presynaptic vesicular glutamate release. In the absence of IL-17,
adult-born neurons receive more synaptic activity, offering a possible
explanation for the increased neurogenesis in the DG of hippocampus.
IL-17 regulates the expression of the proneuronal and proglial
genes in adult-born DG neural stem cells. Since most of the
neuronal progenitors are regulated by proneural genes, we asked
whether the expressions of these proneural genes were changed in
IL-17 KO progenitors. By using real-time RT-PCR techniques, we
measured the messenger expression levels of neurogenin 2 (Ngn2),
mammalian achaete-scute homolog 1 (Mash1), and neurogenic

Figure 3 | Deficiency of IL-17 alters the expression of inflammatory cytokines in the adult DG of hippocampus. ELISA results show that genetic
deletion of IL-17 alters the expression of TNFa, IL-1, IL-4, IL-6, IL-10, and IFN-c at protein level as compared to WT controls. Data were from four
individual experiments performed in triplicate. Means 6 SEM; *p , 0.05; **p , 0.01.
SCIENTIFIC REPORTS | 4 : 7554 | DOI: 10.1038/srep07554
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Figure 4 | Deficiency of IL-17 facilitates basal synaptic transmission in DG of hippocampal slices. (A). For field potential recordings from slices of
hippocampal DG, the stimulating electrode was placed in the angular bundle of the perforant path and a recording electrode in the hilus of the DG.
(B). LTP recordings from the adult hippocampus DG shows no difference between WT and IL-17KO mice. (C). Input/output (I/O) curves relating the
various input intensity (mV) to the slope of fEPSP in the DG region of adult IL-17 KO and WT mice. (D). Enhanced paired-pulse facilitation in the DG of
hippocampal slices from IL-17 KO mice. Paired-pulse facilitation across different inter-stimulus intervals (50–500 ms) is increased in the DG of
hippocampal slices from IL-17 KO mice. (n 5 6 mice per group). Means 6 SEM; **p , 0.01.

differentiation factor 1 (NeuroD1). IL-17 KO progenitors exhibited
increased expression of Ngn2, Mash1, and NeuroD1 compared to
WT controls after 3 days in differentiation medium (Figure 6). In
addition, reduced gliagenic differentiation genes, i.e. HES1 and ld2
were observed in IL-17 KO progenitors as well (Figure 6). These
findings suggest that the elevated messenger expression of neurogenic gene and reduced expression of gliagenic differentiation genes
may be related to the increased differentiation toward neurons in IL17-KO progenitors.

Discussion
By using IL-17 KO mice, we provide the first evidence that IL-17
negatively regulates neurogenesis in the adult DG in vivo under noninflammatory conditions. We observed enhanced intrinsic neuronal
excitability, increased basal excitatory synaptic transmission, and
altered cytokine environment in the hippocampal DG of IL-17 KO
mice. In addition, we also demonstrate that genetic deletion of IL-17
promotes the mRNA expression of pro-neuronal genes. Considering
that there is no evidence of any developmental abnormalities in the
IL-17 KO mice that would explain the observed alterations of hippocampal neurogenesis, our findings suggest a profound role of endogenous IL-17 in the negative regulation of hippocampal neurogenesis
and its impact on the cytokine environment as well as basal
neurotransmission.
Previous findings have revealed a pivotal role of IL-17 in the
pathogenesis of CNS inflammatory diseases11,12, but the physiological
function of IL-17 is much less studied. One recent report suggests
suppressive effects of exogenous IL-17 on the proliferation of stem
cells in vitro35. However, the role of endogenous IL-17 in the hippocampal neurogenesis remains unknown. By using IL-17 KO mice, we
show that endogenous IL-17 negatively regulates neurogenesis in the
DG. We found that progenitor cell proliferation in hippocampal DG
was enhanced in IL-17 KO mice as compared to their WT counterparts. BrdU1 cells from the DG of IL-17 KO mice showed positive
staining of DCX at 2 weeks post BrdU injection, supporting that the
proliferating cells were NPCs36. Moreover, BrdU1 cells from the DG
SCIENTIFIC REPORTS | 4 : 7554 | DOI: 10.1038/srep07554

of IL-17 KO mice showed higher numbers of DCX1 staining 2 weeks
post BrdU injection, reflecting the increased SGZ proliferation. The
increased numbers of BrdU1 NeuN1 cells in the DG of IL-17 KO
mice was seen 4 weeks post BrdU injection, which suggests increased
newly born mature neurons in the SGZ. Both IL-17 and its receptors
were found expressed in the DG tissue, IL-17R was also found
expressed in the cultured progenitors, supporting that the effects of
the ligand are directly mediated by IL-17R on these cells.
It’s reported that IL-17 is produced by CNS glia cells and the IL
17R is expressed by various CNS cells13–15. One recent study also
showed that IL-17 treatment can reduce NPC proliferation and differentiation by acting on IL-17R in vitro35. In the present study, we
identified astrocytes as a major source of IL-17 in the DG tissues, and
IL-17R is expressed by NPCs. Our results show the anti-proneurogenic effects of proinflammatory cytokines, because loss of endogenous IL-17 potentiates neurogenesis, as evidenced by the experiments
with IL-17 KO mice in vivo. Nevertheless, the role of IL-17 in neurogenesis during pathological conditions and in the cross-talk
between glial cells and NPCs require further investigation, which
could be a relevant molecular link during the development of neuroinflammation and brain repair. Additionally, whether IL-17 deletion can improve learning and memory behavior remains unclear,
future investigations are warranted to reveal the potential impact of
IL-17 on cognitive functions.
Neurogenesis is affected by their local cytokine environment. For
example, several studies show that TNF-a, IL-1b and IL-6 inhibit
neurogenesis by activating their receptors10,37–41. The net effects of IL17 on neurogenesis are most likely dependent on its levels and on the
expression of IL-17R in the progenitor cells. IL-17 binds to IL-17R
with high affinity42,43. The altered CNS inflammatory environment
may underlie this enhanced neurogenesis in the DG. On the other
hand, the intracellular mechanisms mediating the actions of IL-17
through its receptor IL-17R on progenitor proliferation and survival
in vivo are largely unknown. Previous findings demonstrated that
activation of IL-17R induced cell apoptosis by activating caspase-3,
caspase-9 and up-regulating the ratio of Bax/Bcl-244. We observed
5
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Figure 5 | Adult-born neurons lacking IL-17 exhibit increased intrinsic excitability and receive more excitatory synaptic activity. (A). A representative
cultured neuron from the adult DG of hippocampus (i.p. injected with Brdu for 4 days before cell dissociation) was recorded and microinjected with
biocytin then immunostained with streptavidin conjugated antibody (green) and BrdU antibody (red). (B). Typical traces of action potential generation
in response to 90 pA current injection (note the -60 mV holding potential and the time course and membrane potential calibration bars) show that
deletion of IL-17 signaling causes increased neuronal excitability in BrdU1 primary cultured neuron from the adult DG of hippocampus. (C). Calculated
input-output relationships for action potential spike activity (ordinate) as a function of currents injected (0-180 pA) in cultured BrdU1 cortical neurons
prepared from the adult DG of hippocampus. Results show that deletion of IL-17 induces the increase of action potential numbers as compared to WT
controls. (D–F). Deletion of IL-17 also increases the amplitude and frequency of mEPSCs recorded from cultured BrdU1 neurons from the DG of
hippocampus as compared to those from WT controls. n 5 8. Means 6 SEM; *p , 0.05; **p , 0.01.

that both IL-17 and IL-17R were expressed in DG tissues as well as in
cultured progenitors (Figure 2), although at a relatively low amount,
which is similar to what has been reported previously in rats and
humans13,45. Thus, the ligand acting on the IL-17R could originate
from the CNS-resident cells including hippocampal progenitors
themselves. In addition, we found that deletion of endogenous IL-

Figure 6 | Endogenous IL-17 regulates the expression of proneuronal and
progial genes. Real-time RT-PCR analysis of the messenger expression
levels of promeuronal genes (NGN2, MASH1, and NeuroD1) and proglia
genes (HES1 and ld2) in cultured NPCs from IL-17 KO and WT mice. The
mRNA expression of NGN2, Mash1, and NeuroD1 were increased in IL-17
KO progenitor cells compared with WT controls. Proglial gene expressions
of HES1 and ld2 were decreased in IL-17 KO progenitors as compared to
WT controls. Data were obtained from four individual experiments
performed in triplicate. Means 6 SEM; *p , 0.05; **p , 0.01.
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17 alters the cytokine environment in the DG tissues, including
several proinflammatory cytokines that may be detrimental for neurogenesis. This altered cytokine microenvironment may be involved
in the enhanced neurogenesis caused by the deletion of IL-17 in the
DG of hippocampus.
Our findings on the deletion of IL-17 promoting basal neurotransmission and intrinsic excitability do not conclude that increased
neurogenesis in IL-17 KO mice results from the neurophysiological
consequences of IL-17 deletion. Recent evidence suggests that neurogenesis can be directly coupled with neuronal excitation46,47, and
the survival of NPC-derived immature neurons through the critical
period depends on their excitatory inputs46–48. Meanwhile, several
lines of studies also support that increased neurogenesis can modulate synaptic transmission and neuronal activities49–51. These studies
have highlighted the link between neurogenesis and neuronal network activities. In this study, we found that deletion of IL-17
increased basal synaptic transmission, as well as the intrinsic excitability and glutamatergic inputs of newly born neurons. These results
suggest that endogenous IL-17 can regulate neuronal network activities. Further investigations are warranted to reveal whether or not
the increased neurogenesis seen in IL-17 KO mice results from these
neurophysiological consequences of IL-17 deletion.
Our results show altered expression of proneural and glia genes in
cultured NPCs from IL-17 KO mice. These findings are consistent
with previous studies that inhibited expression of glia fate genes but
increased proneural genes promotes neurogenesis36,46. We found that
6
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deletion of IL-17 down-regulates Hes1 and Id2 and up-regulates
MASH1, NGN2, and NeuroD messengers in cultured NPCs, which
may be related to the increased differentiation toward neurons seen
in IL-17-KO progenitors.
Our data shows that endogenous IL-17 can negatively regulate
adult neurogenesis in the DG of hippocampus. However, caveats
should be taken when extrapolate these findings to all adult neurogenesis, including neurogenesis in the subventricular zone. Future
studies are needed to further clarify whether endogenous IL-17 can
influence neurogenesis in other brain regions as well.
In summary, we have demonstrated the involvement of endogenous IL-17 in the negative regulation of adult hippocampal neurogenesis under non-inflammatory conditions. Given that circumstantial
evidence indicates a link between hippocampal neurogenesis and
cognitive function52, our findings suggest that the ablation of endogenous IL-17 may serve as a potential strategy to promote adult
hippocampal neurogenesis.
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